Collaborators. A third party in a contractual arrangement with the Performer whereby Xxxxxx has agreed to jointly research, develop and/or commercialize and has an active role in such arrangement. For the avoidance of doubt, an “active role” by Xxxxxx is a contractual relationship (1) that involves more than the mere transfer of intellectual property, and (2) where Xxxxxx has a significant participation in decisionmaking and/or funding of the activities. Collaborators include all parties in collaborations with Amyris as of the effective date, even if the collaboration is modified or amended after the effective date. Data: Recorded information, regardless of form or method of recording, which includes but is not limited to, technical data, software, and trade secrets. The term does not include financial, administrative, cost, pricing or management information and does not include Subject Inventions, included in Article VII.
Collaborators. A third party in a contractual arrangement with the Performer or with a Subcontractor, whether executed before or after the Effective Date, under which arrangement the Performer or a Subcontractor has agreed to jointly research, develop and/or commercialize a technology or product with such third party and has an “active role” in such arrangement. For the avoidance of doubt, an “active role” by the Performer or a Subcontractor is a contractual relationship (1) that involves more than the mere transfer of intellectual property and (2) where the Performer or a Subcontractor has a significant participation in decision making and/or funding of the activities. Data: Recorded information, regardless of form or method of recording, which includes but is not limited to, scientific or technical data, software, trade secrets, and mask works, in each case developed or generated by the Performer or its Subcontractors in performing the Program under this Agreement. The term “Data” does not include financial, administrative, cost, pricing or management information.
Collaborators. (a) BCC may not involve any Collaborators without the prior written approval of KCE (which approval KCE shall not unreasonably withhold or delay). Together with its request for approval, BCC shall submit to KCE the final (draft) BCC’s Collaboration Agreement. BCC shall ensure that the terms and conditions of any such BCC’s Collaboration Agreement complies with the terms and conditions of this Agreement, in particular in respect of arrangements in relation to dissemination of Results and ownership, exploitation and access rights to Results.
Collaborators. Set forth on Schedule 3.17.1 is a list, by the Company, of the material collaborators, research partners and other material service providers of the Company. For the purposes of this Section “material collaborators” means scientific research collaborators who work with the Company and whose work is expected to impact the development of the Company Intellectual Property and/or the Products, and includes, without limitation, any Person to whom the Company has licensed any of the Company Intellectual Property (collectively, the “Collaborators”). To the best of the Company’s knowledge, the Company maintains good working relationships with all of the Collaborators. The Company has delivered or made available to the Purchasers a list of the Company’s Contracts with the Collaborators as set forth on Schedule 3.17.1. Except as set forth on Schedule 3.17.1, none of such Collaborators has terminated or indicated an intention or plan or, to the knowledge of the Company, threatened to terminate its Contract with the Company, or to materially reduce the purchases of products or services from the Company historically made by such Collaborator.
Collaborators. The Parties agree that it may be necessary or useful for Arsanis to enter into collaborations with Third Parties that are academic or non-profit institutions and not fee-for-service contractors (as described in Section 2.8(a) above), are not primarily in the commercial antibody discovery business, and provide Know-How and other intellectual property that are necessary or useful for Arsanis to perform its obligations under the Collaboration and to evaluate Program Antibodies in order to determine whether to exercise one or more Options under this Agreement. Arsanis’ agreement with any such Third Party shall contain (i) restrictions on the use of Adimab Materials consistent with Section 2.6 (including the prohibition on using Program Antibodies in screening), (ii) confidentiality and non-use provisions that are no less stringent than those set forth in Article 6 of this Agreement, and (iii) provisions that ensure that any and all data and results arising out of the Third Party collaboration may be provided to Adimab as and to the extent contemplated under this Agreement. Arsanis shall use commercially reasonable efforts to ensure that it obtains the right to assign, license or sublicense to Adimab any intellectual property rights arising out of the Third Party collaboration that constitutes an Adimab Platform/Core Technology Improvement, or, if it believes it will not be practicable to obtain such right to assign, license or sublicense to Adimab, then Arsanis shall not disclose or transfer to the applicable Third Party (x) any Adimab Confidential Information other than Program Antibody sequences or (y) any Adimab Materials other than Program Antibody samples.
Collaborators. A paid subscription is required in order to create Sheets and perform certain other actions in the Online Service. However, no additional fees are required to share Sheets with Collaborators. Depending on the sharing settings chosen by the Sheet Owner, a Collaborator invited to share a Sheet may share it with others and/or upload, download, view, publish and modify the content stored on that Sheet.
Collaborators. Notwithstanding anything in this Article 14 to the contrary, provided Tenant is not in default under this Lease beyond any applicable notice and cure period, without being subject to Landlord’s rights and Tenant’s obligations set forth in Sections 14.1 through 14.6 above, upon not less than ten (10) days’ prior written notice thereof to Landlord, but without Landlord’s consent, Tenant may permit Collaboration (as hereinafter defined) by Permitted Transferees and/or Clients and Business Partners (as hereinafter defined), without the same constituting a Transfer. The term “Clients and Business Partners” means persons or entities who are occupying or using portions of the Premises and are either (a) performing services for Tenant as subcontractors under Tenant’s contracts, (b) personnel employed by persons or entities for whom Tenant is performing services on a contractual basis, or (c) personnel employed by persons or entities with whom Tenant is engaged in a joint venture or joint teaming effort. The term “Collaboration” means the use of portions of the Premises by Permitted Transferees and/or Clients and Business Partners, if, with respect to such Clients and Business Partners, such use is in connection with the services being provided to Tenant by the applicable Clients and Business Partners, the services being provided to the applicable [Decipher Biosciences, Inc.] Clients and Business Partners by Tenant, or the services being jointly provided by Tenant and the applicable Clients and Business Partners; provided, however, that no Permitted Transferees or Clients and Business Partners shall be deemed to be engaging in Collaboration if such Permitted Transferees or Clients and Business Partners enter into a sublease with Tenant (as opposed to a provision in a contract for goods or office services that contemplates co-location) or has any written leasehold interest in the Premises or any portion thereof. Any Collaboration shall be on and subject to the following conditions: (i) each individual or entity shall be of a character and reputation consistent with the quality of the Building and the Project; (ii) no individual or entity shall occupy a separately demised portion of the Premises or which contains an entrance to such portion of the Premises other than the primary entrance to the Premises; (iii) the rent, if any, paid by such occupants shall not be greater than the rent allocable on a pro rata basis to the portion of the Premises occupied by such occup...
Collaborators. Set forth on Schedule 3.19.1 is a list of the material collaborators, research partners and other material service providers of the Company that are not disclosed in Schedule 3.7.1. For the purposes of this Section “material collaborators” means scientific research collaborators who work with the Company and whose work is expected to impact the development of the Boston Intellectual Property and/or the Products, and includes, without limitation, any Person to whom the Company has licensed any of the Boston Intellectual Property (collectively, the “Collaborators”). To the best of the Company’s knowledge, the Company maintains good working relationships with all of the Collaborators. The Company has made available to the Purchasers a list of its Contracts with the Collaborators as set forth on Schedule 3.19.1. None of such Collaborators has terminated or indicated an intention or plan or, to the knowledge of the Company, threatened to terminate its Contract with the Company, or to materially reduce the purchases of products or services from the Company historically made by such Collaborator.
Collaborators. Collaborators are national, regional, and global-level organizations with a commitment to RRI objectives and who participate in the planning and implementation of RRI-sanctioned activities and strategies.
Collaborators. A paid subscription is required in order to create Sheets. However, Creators may invite anyone with a valid email address to access and use a Sheet. A “Collaborator” is anyone with a Smartsheet login that has been invited to share a Sheet by its Creator. No Service Fee is required for Collaborators. Depending on the sharing settings chosen by a Sheet’s Creator, a Collaborator invited to share a Sheet may share it with other Smartsheet users and/or upload, download, view and modify the content stored on that Sheet.
